Pain relief and palliative care are unavailable to most
Most people who die of cancer worldwide do so without adequate pain relief.
Palliative care improves quality of life, reduces depression and, in at least one landmark randomised trial, lengthened survival when introduced at diagnosis of metastatic lung cancer, yet WHO estimates that only about 14% of people who need palliative care worldwide receive it. Access to opioids, the essential and inexpensive treatment for cancer pain, is restricted in most low- and middle-income countries by regulation, fear of diversion, and lack of trained prescribers, so that the poorest half of the world uses a tiny fraction of the morphine-equivalent opioids consumed by the richest countries. Even in high-income systems, palliative care is introduced late, often in the last weeks of life, and is still confused with hospice. The Lancet Commission's essential package of palliative care costs a few dollars per capita; the bottleneck is policy, training and the position of palliative care within oncology, not science.
- Opioid regulations designed to prevent diversion block legitimate medical use in most low- and middle-income countries.
- Palliative care is not integrated into oncology training or cancer plans in many countries.
- Clinicians and patients equate palliative care with giving up, so referral happens late.
- Palliative services are funded poorly relative to disease-directed treatment.
- Workforce shortages leave no one to prescribe, dispense or deliver home-based care.
- The Lancet Commission on Global Access to Palliative Care and Pain Relief defined an essential package and costed it for low- and middle-income countries.
- World Health Assembly resolution WHA67.19 (2014) commits member states to integrate palliative care into health systems.
- Hospice Africa Uganda's affordable oral morphine model has been adopted across several African countries.
- ASCO's clinical practice guideline (2017) recommends integration of palliative care with standard oncology care from diagnosis of advanced cancer.
- ESMO Designated Centres of Integrated Oncology and Palliative Care accredit hospitals that embed palliative care within oncology.
- The International Narcotics Control Board and WHO work with countries to balance opioid availability with control.
Children with cancer, and their families, need symptom relief and support from diagnosis, not only at the end. Every children's cancer unit should have a palliative team, and most in poorer countries have none.
When a prediction model says a patient has a high chance of dying within a year, their team is prompted to have a structured conversation about what matters to them, while there is still time to act on it.
Palliative care given from the start of treatment for advanced cancer improves quality of life and may extend it. Instead of waiting for an oncologist to remember, the system should refer automatically when the diagnosis is recorded.
Millions of community health workers already visit homes for vaccines and maternal care. Training them to recognise cancer warning signs, guide patients through the system and support home pain care would reach people no hospital does.
Most of the money in cancer goes to treatments that help a few people for a short time, while pain relief for the dying, which is cheap and works, gets almost nothing. Ring-fencing a small fixed share would change that.
Most people in poorer countries die at home without any professional support. A simple kit of medicines and supplies plus a few hours of training for a family member could make dying far less painful.
Uganda makes liquid morphine from powder in a simple facility and lets trained nurses prescribe it, giving pain relief to patients that no doctor will ever reach. Other countries could copy this within a year.
Hospitals publish survival and infection rates but almost never how many of their cancer patients are in uncontrolled pain. Measuring and publishing it would make pain a priority.
Most of the world's people who die in cancer pain have no access to morphine, a drug that costs pennies, because of restrictive national rules. Fixing the rules, not inventing new drugs, is the answer.
Palliative care given early alongside cancer treatment improves quality of life and sometimes survival, and most of the world has no access to it or to morphine. Make both universal.
The Lancet Commission defined a cheap basic package of drugs, equipment and staff for palliative care. Countries expanding health coverage should include it as a guaranteed benefit.
One radiotherapy session relieves bone pain as well as ten, according to many trials, yet most patients still get the longer course. Making one session the default would spare patients trips and free machines.
Patients with advanced cancer often never have a clear conversation about what to expect and what matters to them. A structured conversation guide, taught to clinicians and prompted by the record, makes these talks happen earlier.
Hospitals have fast, standard responses to sepsis and heart attacks. Cancer wasting has no such pathway, so it is noticed late and treated inconsistently.
When morphine is unavailable, patients get nothing. Some cheap alternatives, such as methadone or tramadol, may work for cancer pain but have not been properly tested in these settings.
A large trial showed that palliative care delivered by video works as well as in person for people with advanced lung cancer. Payers should cover it so that distance from a hospital no longer decides who gets it.
In Kerala, trained community volunteers, backed by nurses and doctors, provide most home palliative care to the dying. The model reaches more people at lower cost than any clinic-based service and could be copied.